Skip to main content
. 2020 Jul 23;1(9):916–924. doi: 10.34067/KID.0000462020

Figure 4.

Figure 4.

Primary, primary assisted, secondary, and functional patency for RCAVFs, upper arm AVFs, and AVGs. Patients are censored for death and transplantation. (A–D) Clinical outcomes of all VAs, excluding VAs that did not mature (n=863). (E–H) Clinical outcomes of all VAs, including nonmatured VAs (n=1041).